nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—DDC—Parkinsons Disease Pathway—UCHL1—gallbladder cancer	0.14	0.14	CbGpPWpGaD
Amantadine—MAOB—Alpha-synuclein signaling—UCHL1—gallbladder cancer	0.138	0.138	CbGpPWpGaD
Amantadine—GRIN2B—ErbB4 signaling events—ERBB4—gallbladder cancer	0.0462	0.0462	CbGpPWpGaD
Amantadine—GRIN2C—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—gallbladder cancer	0.035	0.035	CbGpPWpGaD
Amantadine—GRIN2D—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—gallbladder cancer	0.0326	0.0326	CbGpPWpGaD
Amantadine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—gallbladder cancer	0.0267	0.0267	CbGpPWpGaD
Amantadine—GRIN2B—ErbB4 signaling events—ERBB2—gallbladder cancer	0.0251	0.0251	CbGpPWpGaD
Amantadine—GRIN2C—CREB phosphorylation through the activation of Ras—HRAS—gallbladder cancer	0.025	0.025	CbGpPWpGaD
Amantadine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—gallbladder cancer	0.0233	0.0233	CbGpPWpGaD
Amantadine—GRIN2D—CREB phosphorylation through the activation of Ras—HRAS—gallbladder cancer	0.0232	0.0232	CbGpPWpGaD
Amantadine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—gallbladder cancer	0.0227	0.0227	CbGpPWpGaD
Amantadine—GRIN2C—Post NMDA receptor activation events—HRAS—gallbladder cancer	0.0206	0.0206	CbGpPWpGaD
Amantadine—GRIN2D—Post NMDA receptor activation events—HRAS—gallbladder cancer	0.0191	0.0191	CbGpPWpGaD
Amantadine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—gallbladder cancer	0.0191	0.0191	CbGpPWpGaD
Amantadine—GRIN2C—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—gallbladder cancer	0.0189	0.0189	CbGpPWpGaD
Amantadine—GRIN2D—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—gallbladder cancer	0.0176	0.0176	CbGpPWpGaD
Amantadine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—gallbladder cancer	0.0166	0.0166	CbGpPWpGaD
Amantadine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—gallbladder cancer	0.0162	0.0162	CbGpPWpGaD
Amantadine—GRIN2A—Post NMDA receptor activation events—HRAS—gallbladder cancer	0.0157	0.0157	CbGpPWpGaD
Amantadine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—gallbladder cancer	0.0145	0.0145	CbGpPWpGaD
Amantadine—GRIN1—Post NMDA receptor activation events—HRAS—gallbladder cancer	0.0137	0.0137	CbGpPWpGaD
Amantadine—GRIN2B—Post NMDA receptor activation events—HRAS—gallbladder cancer	0.0133	0.0133	CbGpPWpGaD
Amantadine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—gallbladder cancer	0.0126	0.0126	CbGpPWpGaD
Amantadine—GRIN1—EPHB-mediated forward signaling—HRAS—gallbladder cancer	0.0126	0.0126	CbGpPWpGaD
Amantadine—GRIN2B—EPHB-mediated forward signaling—HRAS—gallbladder cancer	0.0123	0.0123	CbGpPWpGaD
Amantadine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—gallbladder cancer	0.0123	0.0123	CbGpPWpGaD
Amantadine—GRIN2C—Alzheimers Disease—TP53—gallbladder cancer	0.0117	0.0117	CbGpPWpGaD
Amantadine—GRIN2D—Alzheimers Disease—TP53—gallbladder cancer	0.0109	0.0109	CbGpPWpGaD
Amantadine—GRIN2A—Alzheimers Disease—TP53—gallbladder cancer	0.00895	0.00895	CbGpPWpGaD
Amantadine—GRIN1—Alzheimers Disease—TP53—gallbladder cancer	0.0078	0.0078	CbGpPWpGaD
Amantadine—GRIN2B—Alzheimers Disease—TP53—gallbladder cancer	0.00761	0.00761	CbGpPWpGaD
Amantadine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.00709	0.00709	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—EGFR—gallbladder cancer	0.00674	0.00674	CbGpPWpGaD
Amantadine—GRIN2D—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.00659	0.00659	CbGpPWpGaD
Amantadine—GRIN1—EPH-Ephrin signaling—HRAS—gallbladder cancer	0.00649	0.00649	CbGpPWpGaD
Amantadine—GRIN2B—EPH-Ephrin signaling—HRAS—gallbladder cancer	0.00633	0.00633	CbGpPWpGaD
Amantadine—GRIN1—Spinal Cord Injury—TP53—gallbladder cancer	0.00566	0.00566	CbGpPWpGaD
Amantadine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.00541	0.00541	CbGpPWpGaD
Amantadine—GRIN2C—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00533	0.00533	CbGpPWpGaD
Amantadine—GRIN2D—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00496	0.00496	CbGpPWpGaD
Amantadine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.00472	0.00472	CbGpPWpGaD
Amantadine—GRIN1—BDNF signaling pathway—HRAS—gallbladder cancer	0.00462	0.00462	CbGpPWpGaD
Amantadine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—gallbladder cancer	0.0046	0.0046	CbGpPWpGaD
Amantadine—GRIN2B—BDNF signaling pathway—HRAS—gallbladder cancer	0.0045	0.0045	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—ERBB2—gallbladder cancer	0.00433	0.00433	CbGpPWpGaD
Amantadine—DDC—Circadian rythm related genes—TP53—gallbladder cancer	0.0043	0.0043	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—ERBB2—gallbladder cancer	0.00423	0.00423	CbGpPWpGaD
Amantadine—GRIN2C—Neuronal System—HRAS—gallbladder cancer	0.00408	0.00408	CbGpPWpGaD
Amantadine—GRIN2A—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00407	0.00407	CbGpPWpGaD
Amantadine—GRIN2D—Neuronal System—HRAS—gallbladder cancer	0.0038	0.0038	CbGpPWpGaD
Amantadine—GRIN1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00355	0.00355	CbGpPWpGaD
Amantadine—GRIN2B—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00346	0.00346	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—NRAS—gallbladder cancer	0.0033	0.0033	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—NRAS—gallbladder cancer	0.00322	0.00322	CbGpPWpGaD
Amantadine—GRIN2A—Neuronal System—HRAS—gallbladder cancer	0.00312	0.00312	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—ERBB2—gallbladder cancer	0.00309	0.00309	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—ERBB2—gallbladder cancer	0.00302	0.00302	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—EGFR—gallbladder cancer	0.003	0.003	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—EGFR—gallbladder cancer	0.00293	0.00293	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—KRAS—gallbladder cancer	0.00284	0.00284	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—KRAS—gallbladder cancer	0.00277	0.00277	CbGpPWpGaD
Amantadine—GRIN1—Neuronal System—HRAS—gallbladder cancer	0.00272	0.00272	CbGpPWpGaD
Amantadine—GRIN2B—Neuronal System—HRAS—gallbladder cancer	0.00265	0.00265	CbGpPWpGaD
Amantadine—GRIN1—Axon guidance—HRAS—gallbladder cancer	0.00241	0.00241	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—NRAS—gallbladder cancer	0.00235	0.00235	CbGpPWpGaD
Amantadine—GRIN2B—Axon guidance—HRAS—gallbladder cancer	0.00235	0.00235	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—NRAS—gallbladder cancer	0.00229	0.00229	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—EGFR—gallbladder cancer	0.00214	0.00214	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—EGFR—gallbladder cancer	0.00209	0.00209	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—KRAS—gallbladder cancer	0.00203	0.00203	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—KRAS—gallbladder cancer	0.00197	0.00197	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	0.00193	0.00193	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	0.00188	0.00188	CbGpPWpGaD
Amantadine—SLC22A2—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00185	0.00185	CbGpPWpGaD
Amantadine—GRIN1—Developmental Biology—HRAS—gallbladder cancer	0.00172	0.00172	CbGpPWpGaD
Amantadine—SLC22A1—Transmission across Chemical Synapses—HRAS—gallbladder cancer	0.00172	0.00172	CbGpPWpGaD
Amantadine—DRD2—Circadian rythm related genes—TP53—gallbladder cancer	0.0017	0.0017	CbGpPWpGaD
Amantadine—GRIN2B—Developmental Biology—HRAS—gallbladder cancer	0.00168	0.00168	CbGpPWpGaD
Amantadine—SLC22A2—Neuronal System—HRAS—gallbladder cancer	0.00141	0.00141	CbGpPWpGaD
Amantadine—SLC22A1—Neuronal System—HRAS—gallbladder cancer	0.00132	0.00132	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	0.0013	0.0013	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	0.00123	0.00123	CbGpPWpGaD
Amantadine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	0.00109	0.00109	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB4—gallbladder cancer	0.000871	0.000871	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB3—gallbladder cancer	0.000753	0.000753	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—NRAS—gallbladder cancer	0.000608	0.000608	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—EGFR—gallbladder cancer	0.000554	0.000554	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—KRAS—gallbladder cancer	0.000523	0.000523	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—ERBB2—gallbladder cancer	0.000472	0.000472	CbGpPWpGaD
Amantadine—DRD2—Signaling by GPCR—HRAS—gallbladder cancer	0.000445	0.000445	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—NRAS—gallbladder cancer	0.000359	0.000359	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—EGFR—gallbladder cancer	0.000327	0.000327	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—KRAS—gallbladder cancer	0.000309	0.000309	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—TP53—gallbladder cancer	0.000275	0.000275	CbGpPWpGaD
Amantadine—DRD2—Signaling Pathways—HRAS—gallbladder cancer	0.000263	0.000263	CbGpPWpGaD
